1 active not recruiting, 1 completed, 1 terminated, 1 unknown. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 1, Completed 1, Terminated 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Sunphenon: new trials by email Literature Review of Sunphenon trials Research Report on Sunphenon
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of Green Tea Catechins in Men on Active Surveillance Sunphenon, Placebo - Prostate Cancer, Prostate Adenocarcinoma | Phase 2 | Active not recruiting | H. Lee Moffitt Cancer Center and Research Institute | 115 | 2020-08-21 | 2026-04-01 |
| Green Tea Extract on Soluble RAGE in Patients With Diabetic Nephropathy green tea extract, Placebo - Diabetic Nephropathy Type 2 | Phase 2 | Unknown | Centro Universitario de Ciencias de la Salud, Mexico | 30 | 2018-07-15 | 2019-02-20 |
| Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer active surveillance, Sunphenon, laboratory biomarker analysis - Stage I Prostate Cancer, Stage IIA Prostate Cancer | Phase 2 | Terminated | Sanjay Gupta PhD | 6 | 2013-08-30 | 2020-10-22 |
| Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study) epigallocatechin-gallate (Sunphenon), placebo - Relapsing-remitting Multiple Sclerosis | Phase 1 / Phase 2 | Completed | Charite University, Berlin, Germany | 120 | 2007-09-01 | 2021-07-29 |
Prostatic Neoplasms (2) · Diabetes Mellitus, Type 2 (1) · Inflammation (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Nerve Degeneration (1)
Centro Universitario de Ciencias de la Salud, Mexico (1) · Charite University, Berlin, Germany (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Sanjay Gupta PhD (1)
United States (2) · Germany (1) · Mexico (1)
Friedemann Paul, Prof., MD (1) · Judith Bellmann-Strobl, Dr., MD (1) · Lee Ponsky, MD (1) · Nagi Kumar, PhD RD FADA (1)
R01CA235032 (1)